{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:25:24Z","timestamp":1761395124476,"version":"3.37.3"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T00:00:00Z","timestamp":1510617600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"NHMRC Practitioner Fellowship","award":["APP1102604"],"award-info":[{"award-number":["APP1102604"]}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"crossref","award":["623204"],"award-info":[{"award-number":["623204"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s10552-017-0981-0","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T02:34:33Z","timestamp":1510626873000},"page":"93-102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Early-onset baldness and the risk of aggressive prostate cancer: findings from a case\u2013control study"],"prefix":"10.1007","volume":"29","author":[{"given":"Nathan P.","family":"Papa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"MacInnis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dallas R.","family":"English","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Bolton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian D.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Lawrentschuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy L.","family":"Millar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Severi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John L.","family":"Hopper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham G.","family":"Giles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,14]]},"reference":[{"key":"981_CR1","volume-title":"Endotext","author":"W Cranwell","year":"2000","unstructured":"Cranwell W, Sinclair R (2000) Male Androgenetic Alopecia. In: De Groot LJ, Beck-Peccoz P, Chrousos G et al (eds) Endotext. MDText.com, Inc, South Dartmouth"},{"key":"981_CR2","unstructured":"Chapter 107. Epidemiology, Etiology, and Prevention of Prostate Cancer. In Wein AJ, Kavoussi LR, Campbell MF, Walsh PC (eds) (2012). Campbell-Walsh urology, 10th edn"},{"issue":"5","key":"981_CR3","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/humu.22046","volume":"33","author":"B Gottlieb","year":"2012","unstructured":"Gottlieb B, Beitel LK, Nadarajah A, Paliouras M, Trifiro M (2012) The androgen receptor gene mutations database: 2012 update. Hum Mutat 33(5):887\u2013894. \n                        https:\/\/doi.org\/10.1002\/humu.22046","journal-title":"Hum Mutat"},{"issue":"4","key":"981_CR4","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1158\/1055-9965.EPI-04-0778","volume":"14","author":"VM Hayes","year":"2005","unstructured":"Hayes VM, Severi G, Eggleton SA, Padilla EJ, Southey MC, Sutherland RL, Hopper JL, Giles GG (2005) The E211 G > A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia. Cancer Epidemiol Prev Biomark 14(4):993\u2013996. \n                        https:\/\/doi.org\/10.1158\/1055-9965.EPI-04-0778","journal-title":"Cancer Epidemiol Prev Biomark"},{"issue":"3","key":"981_CR5","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1046\/j.1523-1747.2001.01261.x","volume":"116","author":"JA Ellis","year":"2001","unstructured":"Ellis JA, Stebbing M, Harrap SB (2001) Polymorphism of the androgen receptor gene is associated with male pattern baldness. J Investig Dermat 116(3):452\u2013455. \n                        https:\/\/doi.org\/10.1046\/j.1523-1747.2001.01261.x","journal-title":"J Investig Dermat"},{"issue":"6","key":"981_CR6","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.jaad.2012.11.034","volume":"68","author":"A Amoretti","year":"2013","unstructured":"Amoretti A, Laydner H, Bergfeld W (2013) Androgenetic alopecia and risk of prostate cancer: a systematic review and meta-analysis. J Am Acad Dermatol 68(6):937\u2013943. \n                        https:\/\/doi.org\/10.1016\/j.jaad.2012.11.034","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"981_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1158\/1055-9965.EPI-12-0860","volume":"22","author":"DC Muller","year":"2013","unstructured":"Muller DC, Giles GG, Sinclair R, Hopper JL, English DR, Severi G (2013) Age-dependent associations between androgenetic alopecia and prostate cancer risk. Cancer Epidemiol Prev Biomark 22(2):209\u2013215. \n                        https:\/\/doi.org\/10.1158\/1055-9965.EPI-12-0860","journal-title":"Cancer Epidemiol Prev Biomark"},{"issue":"6","key":"981_CR8","first-page":"549","volume":"11","author":"GG Giles","year":"2002","unstructured":"Giles GG, Severi G, Sinclair R, English DR, McCredie MR, Johnson W, Boyle P, Hopper JL (2002) Androgenetic alopecia and prostate cancer: findings from an Australian case-control study. Cancer Epidemiol Prev Biomark 11(6):549\u2013553","journal-title":"Cancer Epidemiol Prev Biomark"},{"issue":"3","key":"981_CR9","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/aje\/kwv190","volume":"183","author":"CK Zhou","year":"2016","unstructured":"Zhou CK, Levine PH, Cleary SD, Hoffman HJ, Graubard BI, Cook MB (2016) Male pattern baldness in relation to prostate cancer-specific mortality: a prospective analysis in the NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 183(3):210\u2013217. \n                        https:\/\/doi.org\/10.1093\/aje\/kwv190","journal-title":"Am J Epidemiol"},{"issue":"5","key":"981_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1200\/JCO.2014.55.4279","volume":"33","author":"CK Zhou","year":"2015","unstructured":"Zhou CK, Pfeiffer RM, Cleary SD, Hoffman HJ, Levine PH, Chu LW, Hsing AW, Cook MB (2015) Relationship between male pattern baldness and the risk of aggressive prostate cancer: an analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. J Clin Oncol 33(5):419\u2013425. \n                        https:\/\/doi.org\/10.1200\/JCO.2014.55.4279","journal-title":"J Clin Oncol"},{"issue":"4","key":"981_CR11","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1158\/1055-9965.EPI-12-0944","volume":"22","author":"C Zeigler-Johnson","year":"2013","unstructured":"Zeigler-Johnson C, Morales KH, Spangler E, Chang BL, Rebbeck TR (2013) Relationship of early-onset baldness to prostate cancer in African-American men. Cancer Epidemiol Prev Biomark 22(4):589\u2013596. \n                        https:\/\/doi.org\/10.1158\/1055-9965.EPI-12-0944","journal-title":"Cancer Epidemiol Prev Biomark"},{"issue":"5","key":"981_CR12","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s10552-013-0182-4","volume":"24","author":"JA Thomas","year":"2013","unstructured":"Thomas JA, Antonelli JA, Banez LL, Hoyo C, Grant D, Demark-Wahnefried W, Platz EA, Gerber L, Shuler K, Eyoh E, Calloway E, Freedland SJ (2013) Androgenetic alopecia at various ages and prostate cancer risk in an equal-access multiethnic case-control series of veterans. Cancer Causes Control 24(5):1045\u20131052. \n                        https:\/\/doi.org\/10.1007\/s10552-013-0182-4","journal-title":"Cancer Causes Control"},{"issue":"8","key":"981_CR13","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1093\/annonc\/mdq695","volume":"22","author":"M Yassa","year":"2011","unstructured":"Yassa M, Saliou M, De Rycke Y, Hemery C, Henni M, Bachaud JM, Thiounn N, Cosset JM, Giraud P (2011) Male pattern baldness and the risk of prostate cancer. Ann Oncol 22(8):1824\u20131827. \n                        https:\/\/doi.org\/10.1093\/annonc\/mdq695","journal-title":"Ann Oncol"},{"key":"981_CR14","doi-asserted-by":"publisher","DOI":"10.3109\/21681805.2016.1145734","author":"S Sarre","year":"2016","unstructured":"Sarre S, Maattanen L, Tammela TL, Auvinen A, Murtola TJ (2016) Postscreening follow-up of the Finnish Prostate Cancer Screening Trial on putative prostate cancer risk factors: vitamin and mineral use, male pattern baldness, pubertal development and non-steroidal anti-inflammatory drug use. Scand J Urol. \n                        https:\/\/doi.org\/10.3109\/21681805.2016.1145734","journal-title":"Scand J Urol"},{"issue":"4","key":"981_CR15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/pros.22927","volume":"75","author":"CK Zhou","year":"2015","unstructured":"Zhou CK, Littman AJ, Levine PH, Hoffman HJ, Cleary SD, White E, Cook MB (2015) Male pattern baldness in relation to prostate cancer risks: an analysis in the VITamins and lifestyle (VITAL) cohort study. Prostate 75(4):415\u2013423. \n                        https:\/\/doi.org\/10.1002\/pros.22927","journal-title":"Prostate"},{"issue":"18","key":"981_CR16","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1016\/j.ejca.2010.05.020","volume":"46","author":"RG Cremers","year":"2010","unstructured":"Cremers RG, Aben KK, Vermeulen SH, den Heijer M, van Oort IM, Kiemeney LA (2010) Androgenic alopecia is not useful as an indicator of men at high risk of prostate cancer. Eur J Cancer 46(18):3294\u20133299. \n                        https:\/\/doi.org\/10.1016\/j.ejca.2010.05.020","journal-title":"Eur J Cancer"},{"issue":"2","key":"981_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.canep.2010.02.003","volume":"34","author":"JL Wright","year":"2010","unstructured":"Wright JL, Page ST, Lin DW, Stanford JL (2010) Male pattern baldness and prostate cancer risk in a population-based case-control study. Cancer Epidemiol 34(2):131\u2013135. \n                        https:\/\/doi.org\/10.1016\/j.canep.2010.02.003","journal-title":"Cancer Epidemiol"},{"issue":"13","key":"981_CR18","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jnci\/94.13.981","volume":"94","author":"R Etzioni","year":"2002","unstructured":"Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R, Gann PH, Feuer EJ (2002) Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 94(13):981\u2013990","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"981_CR19","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.juro.2007.11.061","volume":"179","author":"SA Boorjian","year":"2008","unstructured":"Boorjian SA, Karnes RJ, Rangel LJ, Bergstralh EJ, Blute ML (2008) Mayo Clinic validation of the D\u2019amico risk group classification for predicting survival following radical prostatectomy. J Urol 179(4):1354\u20131360. \n                        https:\/\/doi.org\/10.1016\/j.juro.2007.11.061\n                        \n                     (discussion 1360\u20131351)","journal-title":"J Urol"},{"issue":"17","key":"981_CR20","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1001\/jama.293.17.2095","volume":"293","author":"PC Albertsen","year":"2005","unstructured":"Albertsen PC, Hanley JA, Fine J (2005) 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 293(17):2095\u20132101. \n                        https:\/\/doi.org\/10.1001\/jama.293.17.2095","journal-title":"JAMA"},{"issue":"11","key":"981_CR21","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/00007611-197511000-00009","volume":"68","author":"OT Norwood","year":"1975","unstructured":"Norwood OT (1975) Male pattern baldness: classification and incidence. Southern medical journal 68(11):1359\u20131365","journal-title":"Southern medical journal"},{"key":"981_CR22","first-page":"115","volume":"60","author":"AJ Stunkard","year":"1983","unstructured":"Stunkard AJ, Sorensen T, Schulsinger F (1983) Use of the Danish Adoption Register for the study of obesity and thinness. Res Publ Assoc Res Nerv Ment Dis 60:115\u2013120","journal-title":"Res Publ Assoc Res Nerv Ment Dis"},{"issue":"3","key":"981_CR23","first-page":"325","volume":"9","author":"W Denmark-Wahnefried","year":"2000","unstructured":"Denmark-Wahnefried W, Schildkraut JM, Thompson D, Lesko SM, McIntyre L, Schwingl P, Paulson DF, Robertson CN, Anderson EE, Walther PJ (2000) Early onset baldness and prostate cancer risk. Cancer Epidemiol Prev Biomark 9(3):325\u2013328","journal-title":"Cancer Epidemiol Prev Biomark"},{"issue":"5","key":"981_CR24","first-page":"523","volume":"9","author":"E Hawk","year":"2000","unstructured":"Hawk E, Breslow RA, Graubard BI (2000) Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the first National Health and Nutrition Examination Survey. Cancer Epidemiol Prev Biomark 9(5):523\u2013527","journal-title":"Cancer Epidemiol Prev Biomark"},{"issue":"17","key":"981_CR25","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1093\/jnci\/dji248","volume":"97","author":"PC Albertsen","year":"2005","unstructured":"Albertsen PC, Hanley JA, Barrows GH, Penson DF, Kowalczyk PD, Sanders MM, Fine J (2005) Prostate cancer and the Will Rogers phenomenon. J Natl Cancer Inst 97(17):1248\u20131253. \n                        https:\/\/doi.org\/10.1093\/jnci\/dji248","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"981_CR26","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/bju.12671","volume":"115","author":"D Danneman","year":"2015","unstructured":"Danneman D, Drevin L, Robinson D, Stattin P, Egevad L (2015) Gleason inflation 1998\u20132011: a registry study of 97,168 men. BJU Int 115(2):248\u2013255. \n                        https:\/\/doi.org\/10.1111\/bju.12671","journal-title":"BJU Int"},{"key":"981_CR27","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1210\/jcem-20-10-1309","volume":"20","author":"JB Hamilton","year":"1960","unstructured":"Hamilton JB (1960) Effect of castration in adolescent and young adult males upon further changes in the proportions of bare and hairy scalp. J Clin Endocrinol Metab 20:1309\u20131318. \n                        https:\/\/doi.org\/10.1210\/jcem-20-10-1309","journal-title":"J Clin Endocrinol Metab"},{"key":"981_CR28","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1001\/jama.1946.02870240008003","volume":"131","author":"C Huggins","year":"1946","unstructured":"Huggins C (1946) Prostatic cancer treated by orchiectomy; the five year results. J Am Med Assoc 131:576\u2013581","journal-title":"J Am Med Assoc"},{"issue":"6 Suppl 1","key":"981_CR29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0090-4295(01)01299-7","volume":"58","author":"WD Steers","year":"2001","unstructured":"Steers WD (2001) 5alpha-reductase activity in the prostate. Urology 58(6 Suppl 1):17\u201324 (discussion 24)","journal-title":"Urology"},{"issue":"10","key":"981_CR30","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1001\/archdermatol.2010.256","volume":"146","author":"JM Mella","year":"2010","unstructured":"Mella JM, Perret MC, Manzotti M, Catalano HN, Guyatt G (2010) Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review. Arch Dermatol 146(10):1141\u20131150. \n                        https:\/\/doi.org\/10.1001\/archdermatol.2010.256","journal-title":"Arch Dermatol"},{"key":"981_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006015.pub3","author":"J Tacklind","year":"2010","unstructured":"Tacklind J, Fink HA, Macdonald R, Rutks I, Wilt TJ (2010) Finasteride for benign prostatic hyperplasia. Cochrane Database Syst Rev. \n                        https:\/\/doi.org\/10.1002\/14651858.CD006015.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"981_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa030660","volume":"349","author":"IM Thompson","year":"2003","unstructured":"Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, Lieber MM, Cespedes RD, Atkins JN, Lippman SM, Carlin SM, Ryan A, Szczepanek CM, Crowley JJ, Coltman CA Jr (2003) The influence of finasteride on the development of prostate cancer. N Engl J Med 349(3):215\u2013224. \n                        https:\/\/doi.org\/10.1056\/NEJMoa030660","journal-title":"N Engl J Med"},{"issue":"18","key":"981_CR33","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1093\/jnci\/djm117","volume":"99","author":"MS Lucia","year":"2007","unstructured":"Lucia MS, Epstein JI, Goodman PJ, Darke AK, Reuter VE, Civantos F, Tangen CM, Parnes HL, Lippman SM, La Rosa FG, Kattan MW, Crawford ED, Ford LG, Coltman CA Jr, Thompson IM (2007) Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial. J Natl Cancer Inst 99(18):1375\u20131383. \n                        https:\/\/doi.org\/10.1093\/jnci\/djm117","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"981_CR34","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1215932","volume":"369","author":"IM Thompson Jr","year":"2013","unstructured":"Thompson IM Jr, Goodman PJ, Tangen CM, Parnes HL, Minasian LM, Godley PA, Lucia MS, Ford LG (2013) Long-term survival of participants in the prostate cancer prevention trial. N Engl J Med 369(7):603\u2013610. \n                        https:\/\/doi.org\/10.1056\/NEJMoa1215932","journal-title":"N Engl J Med"},{"key":"981_CR35","unstructured":"FDA drug safety communication: 5-alpha reductase inhibitors (5-ARIs) may increase the risk of a more serious form of prostate cancer. 2011. \n                        http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm258314.htm\n                        \n                    . Retrieved July 2016"},{"key":"981_CR36","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.1776","author":"S Sanke","year":"2016","unstructured":"Sanke S, Chander R, Jain A, Garg T, Yadav P (2016) A comparison of the hormonal profile of early androgenetic alopecia in men with the phenotypic equivalent of polycystic ovarian syndrome in women. JAMA Dermatol. \n                        https:\/\/doi.org\/10.1001\/jamadermatol.2016.1776","journal-title":"JAMA Dermatol"},{"issue":"2","key":"981_CR37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4103\/0974-7753.122961","volume":"5","author":"S Narad","year":"2013","unstructured":"Narad S, Pande S, Gupta M, Chari S (2013) Hormonal profile in Indian men with premature androgenetic alopecia. Int J Trichology 5(2):69\u201372. \n                        https:\/\/doi.org\/10.4103\/0974-7753.122961","journal-title":"Int J Trichology"},{"issue":"2","key":"981_CR38","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10552-015-0695-0","volume":"27","author":"JM Schenk","year":"2016","unstructured":"Schenk JM, Till C, Hsing AW, Stanczyk FZ, Gong Z, Neuhouser ML, Reichardt JK, Hoque AM, Figg WD, Goodman PJ, Tangen CM, Thompson IM (2016) Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial. Cancer Causes Control 27(2):175\u2013182. \n                        https:\/\/doi.org\/10.1007\/s10552-015-0695-0","journal-title":"Cancer Causes Control"},{"issue":"3","key":"981_CR39","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/jnci\/djm323","volume":"100","author":"AW Roddam","year":"2008","unstructured":"Roddam AW, Allen NE, Appleby P, Key TJ (2008) Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst 100(3):170\u2013183. \n                        https:\/\/doi.org\/10.1093\/jnci\/djm323","journal-title":"J Natl Cancer Inst"},{"issue":"4850","key":"981_CR40","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1126\/science.3353727","volume":"240","author":"DB Lubahn","year":"1988","unstructured":"Lubahn DB, Joseph DR, Sullivan PM, Willard HF, French FS, Wilson EM (1988) Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 240(4850):327\u2013330","journal-title":"Science"},{"issue":"1","key":"981_CR41","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1086\/431425","volume":"77","author":"AM Hillmer","year":"2005","unstructured":"Hillmer AM, Hanneken S, Ritzmann S, Becker T, Freudenberg J, Brockschmidt FF, Flaquer A, Freudenberg-Hua Y, Jamra RA, Metzen C, Heyn U, Schweiger N, Betz RC, Blaumeiser B, Hampe J, Schreiber S, Schulze TG, Hennies HC, Schumacher J, Propping P, Ruzicka T, Cichon S, Wienker TF, Kruse R, Nothen MM (2005) Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. Am J Hum Genet 77(1):140\u2013148. \n                        https:\/\/doi.org\/10.1086\/431425","journal-title":"Am J Hum Genet"},{"issue":"6","key":"981_CR42","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1111\/j.1523-1747.2003.12615.x","volume":"121","author":"DR Nyholt","year":"2003","unstructured":"Nyholt DR, Gillespie NA, Heath AC, Martin NG (2003) Genetic basis of male pattern baldness. J Investig Dermatol 121(6):1561\u20131564. \n                        https:\/\/doi.org\/10.1111\/j.1523-1747.2003.12615.x","journal-title":"J Investig Dermatol"},{"issue":"5 Pt 1","key":"981_CR43","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0190-9622(84)80498-3","volume":"11","author":"W Kuster","year":"1984","unstructured":"Kuster W, Happle R (1984) The inheritance of common baldness: two B or not two B? J Am Acad Dermatol 11(5 Pt 1):921\u2013926","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"981_CR44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000078584","volume":"209","author":"WC Chumlea","year":"2004","unstructured":"Chumlea WC, Rhodes T, Girman CJ, Johnson-Levonas A, Lilly FR, Wu R, Guo SS (2004) Family history and risk of hair loss. Dermatology 209(1):33\u201339. \n                        https:\/\/doi.org\/10.1159\/000078584","journal-title":"Dermatology"},{"issue":"5","key":"981_CR45","doi-asserted-by":"publisher","first-page":"e1002746","DOI":"10.1371\/journal.pgen.1002746","volume":"8","author":"R Li","year":"2012","unstructured":"Li R, Brockschmidt FF, Kiefer AK, Stefansson H, Nyholt DR, Song K, Vermeulen SH, Kanoni S, Glass D, Medland SE, Dimitriou M, Waterworth D, Tung JY, Geller F, Heilmann S, Hillmer AM, Bataille V, Eigelshoven S, Hanneken S, Moebus S, Herold C, den Heijer M, Montgomery GW, Deloukas P, Eriksson N, Heath AC, Becker T, Sulem P, Mangino M, Vollenweider P, Spector TD, Dedoussis G, Martin NG, Kiemeney LA, Mooser V, Stefansson K, Hinds DA, Nothen MM, Richards JB (2012) Six novel susceptibility Loci for early-onset androgenetic alopecia and their unexpected association with common diseases. PLoS Genet 8(5):e1002746. \n                        https:\/\/doi.org\/10.1371\/journal.pgen.1002746","journal-title":"PLoS Genet"},{"issue":"11","key":"981_CR46","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/ng.255","volume":"40","author":"JB Richards","year":"2008","unstructured":"Richards JB, Yuan X, Geller F, Waterworth D, Bataille V, Glass D, Song K, Waeber G, Vollenweider P, Aben KK, Kiemeney LA, Walters B, Soranzo N, Thorsteinsdottir U, Kong A, Rafnar T, Deloukas P, Sulem P, Stefansson H, Stefansson K, Spector TD, Mooser V (2008) Male-pattern baldness susceptibility locus at 20p11. Nat Genet 40(11):1282\u20131284. \n                        https:\/\/doi.org\/10.1038\/ng.255","journal-title":"Nat Genet"},{"issue":"16","key":"981_CR47","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1038\/onc.2010.560","volume":"30","author":"X Yu","year":"2011","unstructured":"Yu X, Wang Y, DeGraff DJ, Wills ML, Matusik RJ (2011) Wnt\/beta-catenin activation promotes prostate tumor progression in a mouse model. Oncogene 30(16):1868\u20131879. \n                        https:\/\/doi.org\/10.1038\/onc.2010.560","journal-title":"Oncogene"},{"issue":"1","key":"981_CR48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ccr.2010.05.024","volume":"18","author":"J Qi","year":"2010","unstructured":"Qi J, Nakayama K, Cardiff RD, Borowsky AD, Kaul K, Williams R, Krajewski S, Mercola D, Carpenter PM, Bowtell D, Ronai ZA (2010) Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors. Cancer Cell 18(1):23\u201338. \n                        https:\/\/doi.org\/10.1016\/j.ccr.2010.05.024","journal-title":"Cancer Cell"},{"issue":"6","key":"981_CR49","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/ejhg.2015.220","volume":"24","author":"F Liu","year":"2016","unstructured":"Liu F, Hamer MA, Heilmann S, Herold C, Moebus S, Hofman A, Uitterlinden AG, Nothen MM, van Duijn CM, Nijsten TE, Kayser M (2016) Prediction of male-pattern baldness from genotypes. Eur J Hum Genet 24(6):895\u2013902. \n                        https:\/\/doi.org\/10.1038\/ejhg.2015.220","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"981_CR50","doi-asserted-by":"publisher","first-page":"e0127852","DOI":"10.1371\/journal.pone.0127852","volume":"10","author":"M Marcinska","year":"2015","unstructured":"Marcinska M, Pospiech E, Abidi S, Andersen JD, van den Berge M, Carracedo A, Eduardoff M, Marczakiewicz-Lustig A, Morling N, Sijen T, Skowron M, Sochtig J, Syndercombe-Court D, Weiler N, Consortium EU-N, Schneider PM, Ballard D, Borsting C, Parson W, Phillips C, Branicki W (2015) Evaluation of DNA variants associated with androgenetic alopecia and their potential to predict male pattern baldness. PLoS ONE 10(5):e0127852. \n                        https:\/\/doi.org\/10.1371\/journal.pone.0127852","journal-title":"PLoS ONE"},{"issue":"6","key":"981_CR51","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/j.1365-2133.2003.05565.x","volume":"149","author":"G Severi","year":"2003","unstructured":"Severi G, Sinclair R, Hopper JL, English DR, McCredie MR, Boyle P, Giles GG (2003) Androgenetic alopecia in men aged 40\u201369 years: prevalence and risk factors. Br J Dermatol 149(6):1207\u20131213","journal-title":"Br J Dermatol"},{"issue":"3","key":"981_CR52","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1046\/j.1365-2133.1999.03030.x","volume":"141","author":"TF Cash","year":"1999","unstructured":"Cash TF (1999) The psychosocial consequences of androgenetic alopecia: a review of the research literature. Br J Dermatol 141(3):398\u2013405","journal-title":"Br J Dermatol"},{"issue":"2","key":"981_CR53","first-page":"122","volume":"10","author":"D Budd","year":"2000","unstructured":"Budd D, Himmelberger D, Rhodes T, Cash TE, Girman CJ (2000) The effects of hair loss in European men: a survey in four countries. Eur J Dermatol 10(2):122\u2013127","journal-title":"Eur J Dermatol"},{"issue":"6","key":"981_CR54","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/0190-9622(92)70134-2","volume":"26","author":"TF Cash","year":"1992","unstructured":"Cash TF (1992) The psychological effects of androgenetic alopecia in men. J Am Acad Dermatol 26(6):926\u2013931","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"981_CR55","doi-asserted-by":"publisher","first-page":"311","DOI":"10.5021\/ad.2012.24.3.311","volume":"24","author":"SH Han","year":"2012","unstructured":"Han SH, Byun JW, Lee WS, Kang H, Kye YC, Kim KH, Kim DW, Kim MB, Kim SJ, Kim HO, Sim WY, Yoon TY, Huh CH, Hwang SS, Ro BI, Choi GS (2012) Quality of life assessment in male patients with androgenetic alopecia: result of a prospective, multicenter study. Ann Dermatol 24(3):311\u2013318. \n                        https:\/\/doi.org\/10.5021\/ad.2012.24.3.311","journal-title":"Ann Dermatol"},{"key":"981_CR56","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1471-2458-4-60","volume":"4","author":"R Taylor","year":"2004","unstructured":"Taylor R, Matassa J, Leavy JE, Fritschi L (2004) Validity of self reported male balding patterns in epidemiological studies. BMC Public Health 4:60. \n                        https:\/\/doi.org\/10.1186\/1471-2458-4-60","journal-title":"BMC Public Health"},{"issue":"10","key":"981_CR57","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.annepidem.2005.02.013","volume":"15","author":"AJ Littman","year":"2005","unstructured":"Littman AJ, White E (2005) Reliability and validity of self-reported male balding patterns for use in epidemiologic studies. Ann Epidemiol 15(10):771\u2013772. \n                        https:\/\/doi.org\/10.1016\/j.annepidem.2005.02.013","journal-title":"Ann Epidemiol"},{"issue":"2","key":"981_CR58","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4103\/0974-7753.58554","volume":"1","author":"M Guarrera","year":"2009","unstructured":"Guarrera M, Cardo P, Arrigo P, Rebora A (2009) Reliability of Hamilton-Norwood classification. Int J Trichology 1(2):120\u2013122. \n                        https:\/\/doi.org\/10.4103\/0974-7753.58554","journal-title":"Int J Trichology"},{"issue":"3","key":"981_CR59","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jaad.2010.12.023","volume":"66","author":"S Arias-Santiago","year":"2012","unstructured":"Arias-Santiago S, Arrabal-Polo MA, Buendia-Eisman A, Arrabal-Martin M, Gutierrez-Salmeron MT, Giron-Prieto MS, Jimenez-Pacheco A, Calonje JE, Naranjo-Sintes R, Zuluaga-Gomez A, Serrano Ortega S (2012) Androgenetic alopecia as an early marker of benign prostatic hyperplasia. J Am Acad Dermatol 66(3):401\u2013408. \n                        https:\/\/doi.org\/10.1016\/j.jaad.2010.12.023","journal-title":"J Am Acad Dermatol"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-017-0981-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-017-0981-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-017-0981-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T04:31:40Z","timestamp":1514953900000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-017-0981-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,14]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["981"],"URL":"https:\/\/doi.org\/10.1007\/s10552-017-0981-0","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"type":"print","value":"0957-5243"},{"type":"electronic","value":"1573-7225"}],"subject":[],"published":{"date-parts":[[2017,11,14]]}}}